Navigation Links
Panel endorses active monitoring and delay of treatment for low-risk prostate cancer
Date:12/8/2011

An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression. However, monitoring strategiessuch as active surveillancehave not been uniformly studied and available data do not yet point to clear follow-up protocols. The panel recommended standardizing definitions and conducting additional studies to clarify which monitoring strategies are most likely to optimize patient outcomes.

"It's clear that many men would benefit from delaying treatment, but there is no consensus on what constitutes observational strategies and what criteria should be used to determine when treatment might ultimately be needed among closely-monitored men," said Dr. Patricia A. Ganz, conference panel chairperson and director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center at the University of California in Los Angeles.

Prostate cancer is the most common non-skin cancer in men in the United States. It is estimated that in 2011, approximately 240,000 men will be newly diagnosed with prostate cancer and 33,000 will die of the disease. More than half of these cancers are localized (confined to the prostate), not aggressive at diagnosis, and unlikely to become life-threatening. However, approximately 90 percent of patients receive immediate treatment, such as surgery or radiation therapy. For many of these patients, treatment has substantial short- and long-term side effects, such as diminished sexual function and loss of urinary control, without clear benefits, such as improved survival. Identifying appropriate management strategies for different subgroups of patients is critical to improving survival and reducing the burden of adverse effects.

Currently, clinicians often describe two alternatives to immediate treatment of low-ri
'/>"/>

Contact: Elizabeth Neilson
elizabeth.neilson@nih.gov
301-496-4999
NIH/National Institutes of Health, Office of Disease Prevention
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Expert Panel Pinpoints Environmental Culprits in Breast Cancer
2. FDA Panels to Weigh Safety of Newer Forms of the Pill
3. Panel of melanoma mutations opens door to new treatment possibilities
4. Many on Medical Guideline Panels Have Conflicts of Interest: Study
5. Panels Rejection of PSA Test Spurs Mixed Reaction From Experts
6. Osteoporosis Drugs Safety Subject of FDA Panel
7. U.S. Panel Recommends Free Coverage of Birth Control
8. FDA Panel Rejects Avastin for Breast Cancer
9. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
10. FDA Panel Delays Action on Dyes Used in Foods
11. FDA Panel Examines Possible Links Between Food Dyes, ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... The Mesothelioma Applied Research Foundation ... support program. This discussion series is part of the Meso Foundation’s larger program ... affected by mesothelioma. , The six week discussion series is tailored to mesothelioma ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... the weekend edition of USA TODAY. This 12-page, glossy, full-color special section hit ... in highly targeted markets totaling approximately 450,000 copies, with an estimated readership of ...
(Date:6/29/2015)... ... June 29, 2015 , ... Lake ... Balboa Care Center”, showcasing its prestigious five-star, premium rating from Medicare. Medicare’s ratings ... Balboa views this rating as indicative of its commitment to providing patients with ...
(Date:6/29/2015)... ... June 29, 2015 , ... A state-of-the-art ... NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first of its kind approved ... positive airway pressure (CPAP), the current standard of care for OSA. , Some ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... announces the Fresh Plus Diaper, a baby invention that makes parenthood less tiring ... projected to reach a market value of USD 52.2 billion in 2017," says ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Lake Balboa Releases New Facility Video of Patient Testimonials 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 2Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 5
... David Llewellyn of Peninsula College of Medicine and Dentistry ... Investigator Research Grant to further his dementia research. New ... applicants who are the most promising researchers who have ... Dr. Llewellyn is the only researcher in ...
... Home nursing visits are as safe and effective as ... medical researchers. "Generally, moms and babies are discharged from ... Ian Paul, M.D., professor of pediatrics and public health ... is scheduled, and they don,t always show up. This ...
... Scientists are reporting development of a fast, reliable new ... of food poisoning that comes from eating fish tainted ... warm waters. The report appears in ACS, journal ... that 20,000-60,000 people every year come down with ciguatera ...
... study accepted for publication in The Endocrine Society,s Journal ... of dairy foods and higher protein resulted in improvements in ... degradation in overweight and obese young women over 16 weeks ... shown that higher body weight is associated with greater bone ...
... seriously ill adults who received care from a medical ... less likely to report medical errors, test duplication, and ... Fund international survey of patients, experiences in the U.S. ... Health Affairs "Web First" article, the study also ...
... News) -- Astronauts who spend six months or more in ... of their eyes, causing their vision to become blurry, according ... these changes may be the result of prolonged exposure to ... other long-term manned space voyages. "In astronauts over age ...
Cached Medicine News:Health News:US grant exclusive for UK dementia researcher 2Health News:US grant exclusive for UK dementia researcher 3Health News:New mothers, newborns happy with home visits 2Health News:Fast new test for terrible form of food poisoning 2Health News:Dairy foods may improve bone health during diet and exercise in overweight premenopausal women 2Health News:New international health survey of sicker adults: Those with a medical home fare better 2Health News:New international health survey of sicker adults: Those with a medical home fare better 3Health News:New international health survey of sicker adults: Those with a medical home fare better 4Health News:New international health survey of sicker adults: Those with a medical home fare better 5Health News:Space Travel Might Lead to Eye Trouble: Study 2
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: